셀리버리 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 셀리버리주주연대, was filed 18 Sept 2023.
셀리버리: what insiders have been doing
셀리버리, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). 셀리버리 has had no insider filing for more than a year; the last one goes back to 14 March 2024.
Other companies in the same sector with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Financial data
· cache
- ●Executives0DART
- 2,081,593 sharesKRXDART:20230918000262Canonical exit: 14 Dec 2023 (T+90)
- 1,870,000 sharesKRXDART:20230407003371
- 560,000 sharesKRXDART:20230330001294
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 6,250 sharesKRXDART:20230215000373Canonical exit: 16 May 2023 (T+90)
- 6,250 sharesShareKRXDART:20230215000374Canonical exit: 16 May 2023 (T+90)
- ●Executives0DART
- 191,666 sharesShareKRXDART:20221025000489
- 3,902,004 sharesKRXDART:20221025000485Canonical exit: 23 Jan 2023 (T+90)
- 3,800 sharesShareKRXDART:20220817000064Canonical exit: 10 Nov 2022 (T+90)
- 20,000 sharesShareKRXDART:20220812000040Canonical exit: 10 Nov 2022 (T+90)
- 3,142,435 sharesShareKRXDART:20220812000026Canonical exit: 10 Nov 2022 (T+90)
- 147,435 sharesShareKRXDART:20220721000120Canonical exit: 17 Oct 2022 (T+90)
- ●Executives0DART
- 170,000 sharesShareKRXDART:20220516002233
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 40 declarations
About 셀리버리
셀리버리 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.
